Rossari Biotech
BSE 543213 · ISIN INE02A801020
10 stories, newest first.
- Earnings call: record quarterly revenue and EBITDA; Board approves land lease for Saudi greenfield plant
- Rossari Biotech files audio recording of Q2 & H1 FY27 earnings conference call held October 19, 2026
- Rossari Biotech reported strong quarter two earnings driven by higher exports and improved margins, even as the stock fell 3.5 percent despite the good numbers
- Rossari Biotech stock up 21% as net profit rose 5% and export sales jumped, in line with street expectations of strong numbers
- Q2 FY27 press release: highest ever quarterly revenue and EBITDA reported
- Rossari Biotech posts record Q2FY27 revenue of Rs. 697.6 crore, up 19.0%; board approves KSA greenfield land lease
- Board approves Q2 and H1 FY27 results; clears land lease for greenfield plant in Saudi Arabia
- Board approves Q2 results, Saudi land lease for greenfield plant
- Rossari Biotech to host Q2 & H1 FY27 earnings conference call on Monday, October 19, 2026 at 04:00 PM IST
- Board meeting on October 17, 2026 to approve September quarter and half year results
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.